Keyword: Novasep

News

Novasep‐PharmaZell Invests €7.3 Million in APIs

27.07.2022 -

Financed in part by the French government’s France Relance plan, Novasep‐PharmaZell is investing €7.3 million in production of active pharmaceuticals (APIs) at its...

News

Novasep and PharmaZell Conclude Merger

19.04.2022 -

Following exclusive negotiations that started last September, German API specialist PharmaZell and French CDMO Novasep have merged as of Apr. 7. The combined group will...

News

Novasep Invests in API Capabilities

21.12.2021 -

Novasep, a French CDMO, has announced a €6 million investment to increase and modernize manufacturing capabilities at its Chasse-sur-Rhône site to support new generation...

News

Novasep and McSAF in ADC Partnership

26.11.2021 -

French CDMO Novasep is collaborating with compatriot biotech McSAF on the preclinical production of Adcitmer, a next-generation antibody drug conjugate (ADC) for treating...

News

Avid Bioservices Expanding Cell and Gene Therapy

25.10.2021 -

Avid Bioservices, a biologics-oriented CDMO based in the US state of California, is building a new plant in Costa Mesa, California, as part of a plan to expand its cell...

News

Pharmazell and Novasep in Exclusive Merger Talks

23.09.2021 -

German API specialist PharmaZell and French CDMO Novasep are in exclusive talks about a merger that the companies say would create a leading European platform in the...

News

Novasep Expands HPAPI Capabilities at Le Mans

18.05.2021 -

French CDMO Novasep is expanding its manufacturing capabilities for highly potent active pharmaceutical ingredients (HPAPIs) at its Le Mans site. The investment of more...

News

Novasep and Lysogene in Gene Therapy Pact

19.06.2020 - French contract services firm Novasep has signed an agreement with compatriot biopharma Lysogene to develop and manufacture LYS-GM101, the latter’s Adeno-Associated Virus (AAV)rh10...